About CVRx Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.cvrx.com/
Frequently Asked Questions
What is the 52-week range for CVRX?
The 52-week high is $11.3 and the 52-week low is $1.5.
What is the P/E ratio for CVRX?
The P/E ratio data is currently unavailable.
What is the dividend yield for CVRX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -152.34%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -84.92%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 4.73.
Analyst Recommendation Trends
Wall Street analyst consensus for CVRX over the last few months:
Latest CVRX News
Top movers analysis one hour before the close of the markets on 2026-09-30: top gainers and losers in today's session.
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday's regular session. Tenon Medical (NASDAQ:TNON) stock increased by 47.25% to $4.02. The market value of their
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
MINNEAPOLIS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the schedule of scientific presentations featuring Barostim at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026. The meeting will be held Oct. 9-12, 2026, in Phoenix. Barostim will be featured across eight events at HFSA,
CVRx To Present Barostim Data And Clinical Research At HFSA Annual Scientific Meeting 2026
CVRx, Inc. (NASDAQ:CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the schedule of
CVRx Appoints John Landry as Chief Financial Officer
Landry Brings Two Decades of Medtech and Public Company Finance ExperienceMINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that John Landry has been appointed Chief Financial Officer, succeeding Jared Oasheim, whose resignation was previously announced. Mr. Landry will
CVRx Appoints John Landry CFO, Effective Oct. 12, Succeeding Jared Oasheim
CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
Beta Bionics, Inc. (BBNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-13 | Binkowski Brent | +26,223 | $2.9147 | $76,432 |
| 2026-08-12 | Binkowski Brent | -1,309 | $2.5502 | $3,338 |
| 2026-06-01 | SHADAN MARTHA | +11,182 | - | - |
| 2026-06-01 | SHADAN MARTHA | +8,720 | - | - |
| 2026-06-01 | Hill, Mitch C. | +11,182 | - | - |
| 2026-06-01 | Hill, Mitch C. | +8,720 | - | - |
| 2026-06-01 | Jain Mudit K. | +11,182 | - | - |
| 2026-06-01 | Jain Mudit K. | +8,720 | - | - |
| 2026-06-01 | Ballinger Kevin J. | +11,182 | - | - |
| 2026-06-01 | Ballinger Kevin J. | +8,720 | - | - |
| 2026-06-01 | Nielsen Kirk G. | +11,182 | - | - |
| 2026-06-01 | Nielsen Kirk G. | +8,720 | - | - |
| 2026-06-01 | SLATTERY JOSEPH P | +11,182 | - | - |
| 2026-06-01 | SLATTERY JOSEPH P | +8,720 | - | - |
| 2026-06-01 | DALE MICHAEL D | +36,252 | - | - |
| 2026-06-01 | DALE MICHAEL D | +29,005 | - | - |
| 2026-03-02 | Adamson Philip B. | -1,262 | $7.9027 | $9,973 |
| 2026-03-02 | Morrison Gregory | +154,500 | - | - |
| 2026-03-02 | Morrison Gregory | +34,000 | - | - |
| 2026-03-02 | John Robert Allen | -3,964 | $7.9025 | $31,326 |
| 2026-03-02 | VERRASTRO PAUL | -1,284 | $7.9021 | $10,146 |
| 2026-03-02 | OASHEIM JARED | -1,744 | $7.9022 | $13,781 |
| 2026-03-02 | Hykes Kevin | -7,763 | $7.9027 | $61,349 |
| 2026-02-27 | Adamson Philip B. | +62,000 | - | - |
| 2026-02-27 | Adamson Philip B. | +41,000 | - | - |
| 2026-02-27 | John Robert Allen | +52,000 | - | - |
| 2026-02-27 | John Robert Allen | +35,000 | - | - |
| 2026-02-27 | VERRASTRO PAUL | +67,000 | - | - |
| 2026-02-27 | VERRASTRO PAUL | +45,000 | - | - |
| 2026-02-27 | OASHEIM JARED | +91,000 | - | - |
| 2026-02-27 | OASHEIM JARED | +61,000 | - | - |
| 2026-02-27 | Binkowski Brent | +23,000 | - | - |
| 2026-02-27 | Binkowski Brent | +15,000 | - | - |
| 2026-02-27 | Hykes Kevin | +238,000 | - | - |
| 2026-02-27 | Hykes Kevin | +159,000 | - | - |
| 2026-02-20 | Jain Mudit K. | +46,800 | $6.3588 | $297,592 |
| 2026-02-18 | Jain Mudit K. | +600 | $4.6417 | $2,785 |
| 2025-11-26 | JOHNSON & JOHNSON | -6,337 | $10.03 | $63,560 |
| 2025-11-26 | JOHNSON & JOHNSON | -6,337 | $10.03 | $63,560 |
| 2025-11-25 | JOHNSON & JOHNSON | -16,000 | $10.03 | $160,480 |
| 2025-11-24 | JOHNSON & JOHNSON | -2,200 | $10.06 | $22,132 |
| 2025-11-21 | JOHNSON & JOHNSON | -500 | $10 | $5,000 |
| 2025-11-12 | JOHNSON & JOHNSON | -1,000 | $10 | $10,000 |
| 2025-11-07 | JOHNSON & JOHNSON | -200 | $10 | $2,000 |
| 2025-11-06 | JOHNSON & JOHNSON | -52,332 | $10.21 | $534,310 |